TrialCancer immunology, immunotherapy : CII2014

Intrinsically de-sialylated CD103(+) CD8 T cells mediate beneficial anti-glioma immune responses.

Emmanuel Jouanneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.